clinical trials
FDA Urges AI Device Manufacturers for Transparency in Testing Data
NeelRatan
The FDA is enhancing oversight of AI medical devices, advocating for manufacturers to disclose more testing and performance details. New guidance emphasizes early engagement with sponsors and addresses potential risks associated with AI technologies in clinical settings.
AI-Designed Drug Offers Hope for Inflammatory Bowel Disease Treatment
NeelRatan
Insilico Medicine has announced positive results from Phase I trials of ISM5411, an AI-designed drug aimed at treating inflammatory bowel disease. The studies conducted in Australia and China show promise for this innovative treatment, reflecting advancements in generative AI for drug development.
